Patient characteristics
n | 27 |
Age at sample, y, mean ± SD | 53 ± 16 |
Sex, % male | 56 |
White blood cell count at sample, median (range) | 22 (2.4-312) |
Status at evaluation | |
Treatment naive | 21 |
Relapsed | 6 |
Response to induction chemotherapy, n = 14 (%) | |
CR | 8 (57) |
NR | 6 (43) |
Cytogenetics, % | |
High | 33 |
Intermediate | 48 |
Good | 19 |
FAB subclass, %* | |
M0 | 8 |
M1 | 16 |
M2 | 8 |
M3 | 8 |
M4 | 39 |
M5 | 16 |
n | 27 |
Age at sample, y, mean ± SD | 53 ± 16 |
Sex, % male | 56 |
White blood cell count at sample, median (range) | 22 (2.4-312) |
Status at evaluation | |
Treatment naive | 21 |
Relapsed | 6 |
Response to induction chemotherapy, n = 14 (%) | |
CR | 8 (57) |
NR | 6 (43) |
Cytogenetics, % | |
High | 33 |
Intermediate | 48 |
Good | 19 |
FAB subclass, %* | |
M0 | 8 |
M1 | 16 |
M2 | 8 |
M3 | 8 |
M4 | 39 |
M5 | 16 |
Does not add up to 100 due to rounding